Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and t...
Hudson Portfolio Management LLC cut its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 2...
The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to...
Cerity Partners LLC decreased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.8% du...
Neuberger Berman Group LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by ...